AI assistant
Sending…
Traws Pharma, Inc. — Director's Dealing 2013
Nov 19, 2013
35199_dirs_2013-11-18_cc5f1a56-1231-4b35-a2e7-9fcf409cd097.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-11-15
Reporting Person: Michael & Jane Hoffman 2013 Descendants (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-15 | Common Stock | P | 5000 | $11.95 | Acquired | 4292800 | Direct |
| 2013-11-15 | Common Stock | P | 5000 | $11.99 | Acquired | 4297800 | Direct |
| 2013-11-15 | Common Stock | P | 1900 | $12.21 | Acquired | 4299700 | Direct |
| 2013-11-15 | Common Stock | P | 7800 | $11.97 | Acquired | 4307500 | Direct |
More from Traws Pharma, Inc.
Annual Report
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Share Issue/Capital Change
2026
May 22
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 8